- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Emageon inks nationwide archiving deal with Kaiser
Emageon has signed a five-year deal to provide image archiving to Kaiser Permanente throughout the U.S. Kaiser has more than eight million members in 11 states and Washington, DC. When fully deployed, Emageon's Enterprise Archive Manager
Emageon has signed a five-year deal to provide image archiving to Kaiser Permanente throughout the U.S. Kaiser has more than eight million members in 11 states and Washington, DC. When fully deployed, Emageon's Enterprise Archive Manager software will manage more than six million diagnostic studies per year at Kaiser's acute-care hospitals and clinics, representing one of the largest enterprise-class diagnostic image archives in the country.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
